title: Renal handling and physiologic effects of the paramagnetic contrast medium, gadolinium-DOTA.
authors.affiliation: Department of Radiology, University of Rochester Medical Center, New York.
authors.forename: R W
authors.initials: RW
authors.lastname: Katzberg
authors.forename: L G
authors.initials: LG
authors.lastname: Sahler
authors.forename: S W
authors.initials: SW
authors.lastname: Duda
authors.forename: T W
authors.initials: TW
authors.lastname: Morris
authors.forename: B A
authors.initials: BA
authors.lastname: McKenna
authors.forename: R C
authors.initials: RC
authors.lastname: Pabico
authors.forename: W L
authors.initials: WL
authors.lastname: Niedrach
authors.forename: F W
authors.initials: FW
authors.lastname: Tonetti
mesh_terms: D000818:Animals; D003287:Contrast Media / Q000493:pharmacokinetics* / Q000494:pharmacology; D004285:Dogs; D005682:Gadolinium / Q000493:pharmacokinetics* / Q000494:pharmacology; D006571:Heterocyclic Compounds / Q000493:pharmacokinetics* / Q000494:pharmacology; D007668:Kidney / Q000187:drug effects* / Q000502:physiology; D008279:Magnetic Resonance Imaging; D009942:Organometallic Compounds / Q000493:pharmacokinetics* / Q000494:pharmacology; D013997:Time Factors
chemical_list: D003287:Contrast Media; D006571:Heterocyclic Compounds; D009942:Organometallic Compounds; C050823:gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate; D005682:Gadolinium